Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth J Zost

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Nature Medicine|July 12, 2020
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike proteinSeth J Zost, Pavlo Gilchuk, Rita E Chen, et al.
Nature|June 21, 2021
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsRita E Chen, Emma S Winkler, James Brett Case, et al.
Nature|July 16, 2020
Potently neutralizing and protective human antibodies against SARS-CoV-2Seth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Journal of Virology|November 10, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariantsThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Nature|May 8, 2024
Computationally restoring the potency of a clinical antibody against OmicronThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Nature Medicine|July 12, 2020
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike proteinSeth J Zost, Pavlo Gilchuk, Rita E Chen, et al.
Nature|June 21, 2021
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsRita E Chen, Emma S Winkler, James Brett Case, et al.
Nature|July 16, 2020
Potently neutralizing and protective human antibodies against SARS-CoV-2Seth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Journal of Virology|November 10, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariantsThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Nature|May 8, 2024
Computationally restoring the potency of a clinical antibody against OmicronThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Pageof 5